|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Radiative heat transfer and thermal characteristics of Fe-based oxides coated SiC and Alumina RPC structures as integrated solar thermochemical reactor显示文摘This paper investigated radiative heat transfer and thermal characteristics of Fe-based oxides coated SiC and Alumina reticulated porous ceramic structures as integrated solar thermochemical reactor.High-flux solar radiation absorption and axial temperature distribution in the ceramic foams reactor were analyzed by adopting surface-to-surface radiation model coupled to the P1approximation for radiation heat transfer.The radiative heat transfer and thermal characteristics of different foam-type RPC structures,including SiC,CeO_2,FeAl_2O_4,NiFeAlO_4,Fe_3O_4/SiC,and NiFe_2O_4/SiC were evaluated.The mass flow rate and foam structural parameters,including the permeability,pore mean cell size,and extinction coefficients have significantly affected the axial temperature distribution,pressure drop,heat transfer,and fluid flow.Integrated porous structure to the solar receiver could maximize the incorporation of redox powder in the reacting medium,lower the pressure drop,and enhance the thermal performance of the thermochemical reacting system.SiC structure was the candidate materials in the case where more heat flux and high axial temperature distribution is needed.However,Fe-based oxide coated Al_2O_3structure could be considered regarding the heat transfer enhancement along with the catalyst activity of oxygen carriers for solar thermochemical reacting system performance. | GUENE LOUGOU Bachirou SHUAI Yong PAN RuMing CHAFFA Gédéon AHOUANNOU Clément ZHANG Hao TAN HePing | 2018 | Science China(Technological Sciences)2018，61，12： | 2 |
| 2 | Biomarkers of aging显示文摘Aging biomarkers are a combination of biological parameters to(i)assess age-related changes,(ii)track the physiological aging process,and(iii)predict the transition into a pathological status.Although a broad spectrum of aging biomarkers has been developed,their potential uses and limitations remain poorly characterized.An immediate goal of biomarkers is to help us answer the following three fundamental questions in aging research:How old are we?Why do we get old?And how can we age slower?This review aims to address this need.Here,we summarize our current knowledge of biomarkers developed for cellular,organ,and organismal levels of aging,comprising six pillars:physiological characteristics,medical imaging,histological features,cellular alterations,molecular changes,and secretory factors.To fulfill all these requisites,we propose that aging biomarkers should qualify for being specific,systemic,and clinically relevant. | Aging Biomarker Consortium Hainan Bao Jiani Cao Mengting Chen Min Chen Wei Chen Xiao Chen Yanhao Chen Yu Chen Yutian Chen Zhiyang Chen Jagadish K Chhetri Yingjie Ding Junlin Feng Jun Guo Mengmeng Guo Chuting He Yujuan Jia Haiping Jiang Ying Jing Dingfeng Li Jiaming Li Jingyi Li Qinhao Liang Rui Liang Feng Liu Xiaoqian Liu Zuojun Liu Oscar Junhong Luo Jianwei Lv Jingyi Ma Kehang Mao Jiawei Nie Xinhua Qiao Xinpei Sun Xiaoqiang Tang Jianfang Wang Qiaoran Wang Siyuan Wang Xuan Wang Yaning Wang Yuhan Wang Rimo Wu Kai Xia Fu-Hui Xiao Lingyan Xu Yingying Xu Haoteng Yan Liang Yang Ruici Yang Yuanxin Yang Yilin Ying Le Zhang Weiwei Zhang Wenwan Zhang Xing Zhang Zhuo Zhang Min Zhou Rui Zhou Qingchen Zhu Zhengmao Zhu Feng Cao Zhongwei Cao Piu Chan Chang Chen Guobing Chen Hou-Zao Chen Jun Chen Weimin Ci Bi-Sen Ding Qiurong Ding Feng Gao Jing-Dong JHan Kai Huang Zhenyu Ju Qing-Peng Kong Ji Li Jian Li Xin Li Baohua Liu Feng Liu Lin Liu Qiang Liu Qiang Liu Xingguo Liu Yong Liu Xianghang Luo Shuai Ma Xinran Ma Zhiyong Mao Jing Nie Yaojin Peng Jing Qu Jie Ren Ruibao Ren Moshi Song Zhou Songyang Yi Eve Sun Yu Sun Mei Tian Shusen Wang Si Wang Xia Wang Xiaoning Wang Yan-Jiang Wang Yunfang Wang Catherine CL Wong Andy Peng Xiang Yichuan Xiao Zhengwei Xie Daichao Xu Jing Ye Rui Yue Cuntai Zhang Hongbo Zhang Liang Zhang Weiqi Zhang Yong Zhang Yun-Wu Zhang Zhuohua Zhang Tongbiao Zhao Yuzheng Zhao Dahai Zhu Weiguo Zou Gang Pei Guang-Hui Liu | 2023 | Science China(Life Sciences)2023，66，5： | 2 |
| 3 | Multriple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects 显示文摘 | Yong CL Dias VC Stangier J | 2000 | J Clin Phannacol2000，，： | 1 |
| 4 | Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide 显示文摘 | Pelocluin CA Jaresko GS Yong CL et ai | 1997 | Antimicrob Agents and Chemother1997，41，12： | 1 |
| 5 | mTOR - beyond transplantation显示文摘 | Yong DA Nickerson-Nutter CL | | 0，，04： | 1 |
| 6 | Pharmacokinetic comparison of an angiotensinⅡ receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method显示文摘 | Tatami S Yamamura N Sarashina A Yong CL Igarashi T Tanigawara Y | 2004 | Drug Metab Pharmacokinet2004，19，1： | 1 |
| 7 | Multiple-dose pharmacokinetics of Telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects显示文摘 | Yong CL Dias VC Stangier J | 2000 | J Clin Pharmacol2000，，： | 1 |
| 8 | Purification,structural analysis and hydroxyl radical-scavenging capacity of a polyszccharide from the fruiting bodies of Russula virescens显示文摘 | YONG XS JI CL XIU DY | 2010 | Process Biochemisty2010，45，6： | 1 |
| 9 | Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol显示文摘 | Dance DR Skinner CL Yong KC | 2000 | Phys Med Biol2000，45，11： | 1 |
| 10 | Population pharma- cokinetic modeling of isoniazid, rifampin, and pyrazinamide 显示文摘 | Peloquin CA Jaresko GS Yong CL | 1997 | Antimicrob Agents Chemother1997，41，12： | 1 |
| 11 | Study of mechanical joint strength of aluminum alloy 7075-T6and dual phase steel 980 weld- ed by friction bit joining and weld-bonding under conrosion medi- um显示文摘 | Yong CL LileS Tsungyu P etal | 2015 | Materials and Design2015，69，： | 1 |
| 12 | Manganese superuide dismutase gene therapy protects against itTadialion-indueed intestinal injury 显示文摘 | Chao Y Hal Xu C Yong Z cl al | 2013 | Cul''r Gene Ther2013，，： | 1 |
| 13 | Vascular endothelial growth factor in patients with acute asthma 显示文摘 | Yong CL Hern KL | 2001 | J Allergy Clin Immunol2001，107，： | 1 |
| 14 | Population pharmacokinetic modeling of isoniazid, rifampin and pyrazinamide显示文摘 | Peloquin CA Jaresko GS Yong CL | 1997 | Antimicrob Agents Chemother1997，41，： | 1 |
| 15 | Radioimmunoguided surgery in primary colorectal carcinoma:a bioprognostic indicator independent of traditional staging显示文摘 | Yong DC Hitchcock CL | 1995 | Am J Surg1995，170，4： | 1 |
| 16 | Safety of donors in live donorliver transplantation using right lobe grafts 显示文摘 | Liu CL Yong BH Ghan JK | 2000 | Arch Surg2000，15，3： | 1 |
| 17 | Long-term follow-up of schistosomiasis serology post-treatment in Australian travelers and immigrants显示文摘 | Yong MK Beckett CL Leder K | 2010 | J Travel Med2010，17，2： | 1 |
| 18 | 环境基质中药物残留的固相提取与分析显示文摘废水流出物常常不可避免地进入地表水和用于饮用水资源的含水层.因废水再循环常常进入饮用水层,各种废水中的污染物最终会污染饮用水.以往环保部门一直比较注重农药和工业污染物,但最近的研究发现:废水流出物中的某些药物残留已达到了相当令人关注(1μg*l-1即ppb)的程度.传统的分析技术(如液液萃取和GC/MS)对极性较弱的化合物(PCBs和许多农药)比较有效,但对于极性相对较强的药物污染物而言,固相提取(SPE)与LC/MS技术更适合于样品提取分析. | Yong,MS Maller,CL | 2001 | 环境化学2001，20，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员